Altered neurovascular control of the resting circulation in human metabolic syndrome

Journal of Physiology

Volumn 590, Issue 23, 2012, Pages 6109-6119

  Limberg, Jacqueline K ^a   Morgan, Barbara J ^b   Sebranek, Joshua J ^b   Proctor, Lester T ^b   Walker, Benjamin J ^b   Eldridge, Marlowe W ^b   Schrage, William G ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; CLONIDINE; PHENYLEPHRINE;

ADULT; ALPHA ADRENERGIC STIMULATION; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOREARM BLOOD FLOW; HUMAN; HYPERTENSION; MALE; METABOLIC SYNDROME X; NEUROGRAPHY; NEUROMODULATION; PATHOGENESIS; PERONEUS NERVE; PRIORITY JOURNAL; SYMPATHETIC NERVE; VASOCONSTRICTION;

ADOLESCENT; ADRENERGIC ALPHA-1 RECEPTOR AGONISTS; ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ADULT; CLONIDINE; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MUSCLE, SKELETAL; PERONEAL NERVE; PHENYLEPHRINE; RECEPTORS, ADRENERGIC, ALPHA; REGIONAL BLOOD FLOW; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTION; YOUNG ADULT;

EID: 84870307844     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2012.239780     Document Type: Article

References (43)

1. Agapitov AV, Correia ML, Sinkey CA & Haynes WG (2008). Dissociation between sympathetic nerve traffic and sympathetically mediated vascular tone in normotensive human obesity. Hypertension 52, 687-695.
2. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM & Smith SC, Jr (2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640-1645.
3. Anderson KM & Faber JE (1991). Differential sensitivity of arteriolar alpha 1- and alpha 2-adrenoceptor constriction to metabolic inhibition during rat skeletal muscle contraction. Circ Res 69, 174-184.
4. Burgdorf C, Richardt G, Schütte F, Dendorfer A & Kurz T (2006). Impairment of presynaptic alpha2-adrenoceptor-regulated norepinephrine overflow in failing hearts from Zucker diabetic fatty rats. J Cardiovasc Pharmacol 47, 256-262.
5. Charkoudian N, Joyner MJ, Sokolnicki LA, Johnson CP, Eisenach JH, Dietz NM, Curry TB & Wallin BG (2006). Vascular adrenergic responsiveness is inversely related to tonic activity of sympathetic vasoconstrictor nerves in humans. J Physiol 572, 821-827.
6. Collop NA, Anderson WM, Boehlecke B, Claman D, Goldberg R, Gottlieb DJ, Hudgel D, Sateia M & Schwab R (2007). Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 3, 737-747.
7. Coppack SW, Horowitz JF, Paramore DS, Cryer PE, Royal HD & Klein S (1998). Whole body, adipose tissue, and forearm norepinephrine kinetics in lean and obese women. Am J Physiol Endocrinol Metab 275, E830-E834.
8. Dincer UD, Araiza AG, Knudson JD, Molina PE & Tune JD (2006). Sensitization of coronary α-adrenoceptor vasoconstriction in the prediabetic metabolic syndrome. Microcirculation 13, 587-595.
9. Dinenno FA, Dietz NM & Joyner MJ (2002). Aging and forearm post-junctional α-adrenergic vasoconstriction in healthy men. Circulation 106, 1349-1354.
10. Dinenno FA, Masuki S & Joyner MJ (2005). Impaired modulation of sympathetic α-adrenergic vasoconstriction in contracting forearm muscle of ageing men. J Physiol 567, 311-321.
11. Dupont WD & Plummer WD, Jr (1998). Power and sample size calculations for studies involving linear regression. Control Clin Trials 19, 589-601.
12. Eklund B & Kaijser L (1976). Effect of regional α- and β-adrenergic blockade on blood flow in the resting forearm during contralateral isometric handgrip. J Physiol 262, 39-50.
13. Esler M (1993). Clinical application of noradrenaline spillover methodology: delineation of regional human sympathetic nervous responses. Pharmacol Toxicol 73, 243-253.
14. Esler M, Straznicky N, Eikelis N, Masuo K, Lambert G & Lambert E (2006). Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 48, 787-796.
15. Faber JE (1988). In situ analysis of alpha-adrenoceptors on arteriolar and venular smooth muscle in rat skeletal muscle microcirculation. Circ Res 62, 37-50.
16. Fagius J & Wallin BG (1993). Long-term variability and reproducibility of resting human muscle nerve sympathetic activity at rest, as reassessed after a decade. Clin Auton Res 3, 201-205.
17. Ford ES (2005). Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28, 1769-1778.
18. Frisbee JC, Goodwill AG, Butcher JT & Olfert IM (2011). Divergence between arterial perfusion and fatigue resistance in skeletal muscle in the metabolic syndrome. Exp Physiol 96, 369-383.
19. Gando S, Hattori Y & Kanno M (1993). Altered cardiac adrenergic neurotransmission in streptozotocin-induced diabetic rats. Br J Pharmacol 109, 1276-1281.
20. Gurdal H, Cai G & Johnson MD (1995). Alpha 1-adrenoceptor responsiveness in the aging aorta. Eur J Pharmacol 274, 117-123.
21. Hanada A, Sander M & Gonzalez-Alonso J (2003). Human skeletal muscle sympathetic nerve activity, heart rate and limb haemodynamics with reduced blood oxygenation and exercise. J Physiol 551, 635-647.
22. Hart EC, Joyner MJ, Wallin BG, Johnson CP, Curry TB, Eisenach JH & Charkoudian N (2009). Age-related differences in the sympathetic-hemodynamic balance in men. Hypertension 54, 127-133.
23. Hogikyan RV, Galecki AT, Halter JB & Supiano MA (1999). Heightened norepinephrine-mediated vasoconstriction in type 2 diabetes. Metabolism 48, 1536-1541.
24. Hogikyan RV & Supiano MA (1994). Arterial alpha-adrenergic responsiveness is decreased and SNS activity is increased in older humans. Am J Physiol Endocrinol Metab 266, E717-E724.
25. Jie K, van Brummelen P, Vermey P, Timmermans PB & van Zwieten PA (1987). Modulation of noradrenaline release by peripheral presynaptic alpha 2-adrenoceptors in humans. J Cardiovasc Pharmacol 9, 407-413.
26. Johnsson G (1967). The effects of intra-arterially administered propranolol and H 56-28 on blood flow in the forearm-a comparative study of two beta-adrenergic receptor antagonists. Acta Pharmacol Toxicol (Copenh) 25, 63-74.
27. Joyner MJ, Charkoudian N & Wallin BG (2010). Sympathetic nervous system and blood pressure in humans: individualized patterns of regulation and their implications. Hypertension 56, 10-16.
28. Lambert E, Straznicky N, Schlaich M, Esler M, Dawood T, Hotchkin E & Lambert G (2007). Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension 50, 862-868.
29. Lesniewski LA, Donato AJ, Behnke BJ, Woodman CR, Laughlin MH, Ray CA & Delp MD (2008). Decreased NO signaling leads to enhanced vasoconstrictor responsiveness in skeletal muscle arterioles of the ZDF rat prior to overt diabetes and hypertension. Am J Physiol Heart Circ Physiol 294, H1840-H1850.
30. Limberg JK, Eldridge MW, Proctor LT, Sebranek JJ & Schrage WG (2010). α-Adrenergic control of blood flow during exercise: effect of sex and menstrual phase. J Appl Physiol 109, 1360-1368.
31. Minson CT, Halliwill JR, Young TM & Joyner MJ (2000). Influence of the menstrual cycle on sympathetic activity, baroreflex sensitivity, and vascular transduction in young women. Circulation 101, 862-868.
32. Mita M, Kuramoto T, Ito K, Toguchi-Senrui N, Hishinuma S, Walsh MP & Shoji M (2010). Impairment of α1-adrenoceptor-mediated contractile activity in caudal arterial smooth muscle from type 2 diabetic Goto-Kakizaki rats. Clin Exp Pharmacol Physiol 37, 350-357.
33. Naik JS, Xiang L, Hodnett BL & Hester RL (2008). α-Adrenoceptor-mediated vasoconstriction is not involved in impaired functional vasodilation in the obese Zucker rat. Clin Exp Pharmacol Physiol 35, 611-616.
34. Netzer N, Eliasson AH, Netzer C & Kristo DA (2001). Overnight pulse oximetry for sleep-disordered breathing in adults: a review. Chest 120, 625-633.
35. Paffenbarger RS, Jr, Blair SN, Lee IM & Hyde RT (1993). Measurement of physical activity to assess health effects in free-living populations. Med Sci Sports Exerc 25, 60-70.
36. Radegran G (1997). Ultrasound Doppler estimates of femoral artery blood flow during dynamic knee extensor exercise in humans. J Appl Physiol 83, 1383-1388.
37. Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR, Wiesner GH, Brunner-La Rocca HP & Esler MD (1999). Neural mechanisms in human obesity-related hypertension. J Hypertens 17, 1125-1133.
38. Scherrer U & Sartori C (1997). Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 96, 4104-4113.
39. Schrage WG, Eisenach JH & Joyner MJ (2007). Ageing reduces nitric-oxide- and prostaglandin-mediated vasodilatation in exercising humans. J Physiol 579, 227-236.
40. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G & Baron AD (1996). Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97, 2601-2610.
41. Stepp DW & Frisbee JC (2002). Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol 282, H816-H820.
42. Sundlof G & Wallin BG (1977). The variability of muscle nerve sympathetic activity in resting recumbent man. J Physiol 272, 383-397.
43. Wallin BG & Charkoudian N (2007). Sympathetic neural control of integrated cardiovascular function: insights from measurement of human sympathetic nerve activity. Muscle Nerve 36, 595-614.